Core Viewpoint - Codere Online has filed its annual report on form 20-F for the year ended December 31, 2024, with the SEC, indicating a step towards compliance with Nasdaq Listing Rule 5250(c)(1) [1][2]. Company Overview - Codere Online is a leading online gaming operator in Spain and Latin America, launched in 2014 as part of the Codere Group, which is known for its casino operations [5]. - The company offers online sports betting and casino services through its website and mobile applications, operating in key markets including Spain, Mexico, Colombia, Panama, and Argentina [5]. Compliance and Regulatory Updates - By filing the 2024 20-F, the company believes it has regained compliance with Nasdaq Listing Rule 5250(c)(1), which may eliminate the need for a hearing regarding a delisting determination [2]. - The company is awaiting formal confirmation from Nasdaq regarding its compliance status [2]. Environmental Considerations - To reduce environmental impact, the company encourages shareholders to read the annual report in digital format, although hard copies are available upon request [4].

Castellum, Inc. to Participate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Castellum, Inc. (NYSE-American: CTM), announces that its Chief Executive Officer, Glen Ives, has been invited to present at the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” presented by Maxim Group LLC, on Tuesday, June 3rd – Thursday, June 5th at 9:00 a.m. EDT - www.castellumus.com VIENNA, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-America ...

Core Insights - Brazil Potash Corp. has made significant progress in governance, commercial partnerships, construction, and financial initiatives for the Autazes Potash Project, which is crucial for Brazil's agricultural security [1][2] Group 1: Achievements and Progress - The company has established a $75 million equity line of credit with Alumni Capital, enhancing its capital access for project advancement [5] - Brazil Potash signed a Memorandum of Understanding (MOU) with Keytrade AG for potential offtake of up to one million tons per year, moving towards approximately 1.5 million tons of committed production [6] - The company has strengthened government relations through strategic meetings with key stakeholders, including the Amazonas State Governor and the Mura Indigenous Council [6] Group 2: Leadership and Governance - Mayo Schmidt was appointed as Executive Chairman in January 2025, bringing experience from Nutrien, the world's largest fertilizer company [6] - Christian Joerg was added to the Board of Directors, contributing three decades of experience in agricultural commodities and international trade finance [6] - The Advisory Board was expanded with Marcelo Lessa, a former IFC/World Bank executive with extensive project financing expertise [6] Group 3: Construction and Operational Advancements - The company received approval to begin fauna rescue and vegetation suppression activities, enabling subsequent shaft sinking operations [6] - Site preparation work at the future port terminal has been completed, marking a critical infrastructure milestone [6] - Water extraction installation licenses have been converted to full operational permits, securing water supply for construction and operations [6] Group 4: Market Context and Future Outlook - Brazil Potash aims to produce up to 2.4 million tons of potash annually, potentially supplying approximately 20% of Brazil's current potash demand [7] - The project is expected to reduce Brazil's reliance on potash imports while mitigating approximately 1.4 million tons per year of greenhouse gas emissions [7]

BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new standard of care in multiple tumor typesThe co-development and co-commercialization collaboration with a 50/50 profit/loss split will leverage both partners’ expertise, resources and global footprint to accelerate BNT327’s path towards potential regulatory approvals and market launchesBioNTech and Bristol Myers ...

Core Viewpoint - Bank of America has upgraded Boeing from Neutral to Buy, raising the price target to $260 from $185, indicating a positive outlook on Boeing's recovery and market positioning [1] Group 1: Market Dynamics - Boeing is regaining momentum in global markets, supported by geopolitical factors and a shift in strategic perception [1] - The Trump Administration has favored Boeing aircraft in recent trade deals, with significant agreements involving the UK (32 aircraft), Qatar (210), the UAE (28), and China lifting its ban on Boeing planes [2] Group 2: Financial Performance - The order backlog is not the primary driver for the valuation upgrade; instead, operational stabilization, strategic measures to improve free cash flow, and a shift in global trade positioning are highlighted as key catalysts [3] - The revised price target of $260 implies a free cash flow of $9 per share, reflecting optimism about Boeing's recovery trajectory [3] Group 3: Stock Market Reaction - Boeing's stock is currently trading at $207.32, with pre-market quotes showing an increase of 1.88% to $211.21, indicating positive investor sentiment following the upgrade [4] - If the analyst's thesis is validated, Boeing's status as a "favored trade mechanism" could significantly influence its next growth cycle [4]

Atacicept ORIGIN Phase 3 trial met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared to placebo at week 36 (p<0.0001)Other prespecified endpoints achieved similar or better results compared to the ORIGIN Phase 2b clinical trial — per FDA guidance, Vera is not sharing eGFR results at this time while the ORIGIN 3 placebo-controlled trial continuesThe safety profile of atacicept was favorable, a ...

Core Insights - Uranium Energy Corp (UEC) is strategically positioned to meet the anticipated increase in uranium demand due to the U.S. government's initiative to quadruple nuclear capacity and rebuild its nuclear industrial base [3][5] - The company has achieved significant operational milestones, including the commissioning of new In-Situ Recovery (ISR) production in Wyoming and advancing construction in South Texas [4][10] - UEC's financial position is strong, with $271 million in cash, inventory, and equities, and no debt as of May 30, 2025 [6] Financial Highlights - UEC filed its quarterly report on Form 10-Q for the quarter ended April 30, 2025, with the SEC, which includes interim condensed consolidated financial statements [2] - The company reported an inventory of 1,356,000 pounds of U3O8 valued at $96.6 million at market prices [6] - UEC plans to expand its U.S. warehoused physical uranium program by 300,000 pounds through purchase contracts in December 2025 at $37.05 per pound [6] Operational Developments - The first new mine unit at Christensen Ranch ISR Mine has been commissioned, marking a significant operational milestone [7] - Construction at the Burke Hollow ISR Project in South Texas is progressing on schedule, with key advances in wellfield development and processing infrastructure [10][12] - UEC's workforce has expanded to over 100 employees in Wyoming and 40 in South Texas, supporting the company's growing operations [6][13] Project Updates - The Roughrider project in Canada is being prepared for pre-feasibility, with metallurgical test work significantly advanced [5][17] - UEC is advancing its hub-and-spoke ISR production platform in Wyoming's Great Divide Basin, with a Technical Report Summary expected by the end of fiscal 2025 [14][16] - The company has initiated efforts to amend conventional mining permits at the Sweetwater Uranium Project to incorporate ISR mining methods [15]

Core Insights - Southwest Airlines and China Airlines are forming an interline partnership to enhance trans-Pacific travel options, marking the first such collaboration for Southwest Airlines [1][2] - The partnership aims to provide seamless travel experiences for customers, allowing them to book itineraries under one ticket and improve connectivity between the U.S. and Asia [2] Company Overview - Southwest Airlines operates one of the most admired airlines globally, serving 117 airports across 11 countries and carrying more domestic passengers than any other airline in the U.S. [5][6] - China Airlines, founded in 1959, employs over 10,000 people and operates a fleet of 111 aircraft, aiming to be a leading airline in the Asia-Pacific region [3][4] Strategic Goals - The partnership aligns with Southwest's vision to expand its network and provide more choices for customers, particularly in California, where it has a significant presence [2] - China Airlines is focused on growing its long-haul network and enhancing gateway operations in key U.S. cities, including Los Angeles and San Francisco [2] Recent Developments - Southwest Airlines recently launched a partnership with Icelandair, further expanding its international connectivity [2] - The announcement of the partnership with China Airlines was made during the IATA 2025 Annual General Meeting in New Delhi, indicating a strategic move to attract global partnerships [1][2]

Atlanta, June 02, 2025 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. ("Piedmont” or “the Company") (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, announced today, that the Company is participating in this week’s Nareit REITWeek Investor Conference in New York City. The Company has completed over 500,000 square feet of leasing thus far in the second quarter, with 350,000 square feet related to new tenants. Approximately 70% of the new tenant leases are for curren ...

YUTREPIA now available to be prescribed to patients via specialty pharmaciesFDA approved YUTREPIA on May 23, 2025Court denies United Therapeutics’ request for preliminary injunction and a temporary restraining order, clearing the path for full commercial launch MORRISVILLE, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that Liquidia is scheduled to make i ...